A high-stakes drama is unfolding in China’s lucrative infant care market, blending consumer anxiety with allegations of corporate manipulation. At the center of the storm is Wang Dongjian, a social media influencer known as "Kaopu Laowang" and the CEO of Bree Bio-Tech. Wang stands accused of orchestrating a public health scare involving formamide residues in baby diapers to drive sales for his company’s specialized detection equipment.
The controversy ignited following a report by the Economic Information Daily, a publication under the state-run Xinhua News Agency. The report alleged that several major diaper brands, including Huggies and Babycare, contained detectable levels of formamide, a substance linked to skin irritation and systemic toxicity. This revelation immediately tapped into the deep-seated fears of Chinese parents, who remain hyper-vigilant regarding product safety since the 2008 melamine milk scandal.
Observers quickly noted a suspicious correlation between the state media report and Wang’s prior social media activities. For weeks leading up to the publication, Wang had been posting videos of self-funded lab tests that mirrored the findings eventually released by the newspaper. This led to accusations that Wang used his platform to manufacture a "mother-and-baby anxiety" crisis to market his firm’s mass spectrometry devices to hospitals and labs.
Wang has since moved to defend his reputation, claiming that his social media presence is purely personal and that his scientific findings are independent of the media's investigation. He argues that the medical equipment industry involves long procurement cycles and clinical partnerships, making it illogical to use a short-term social media panic as a primary sales strategy. Despite his defense, several of his social media accounts have been scrubbed or locked as public pressure mounts.
The situation has devolved into what local media calls a "Rashomon" of conflicting testimonies. While the original report cited experts from the Shandong Public Health Clinical Center, the institution and its lead researchers later issued denials, claiming they never spoke to the journalist. In response, the reporting journalist released audio recordings suggesting that the experts were pressured by their superiors to retract their statements to avoid corporate blowback.
Faced with a brewing national crisis and conflicting scientific data, Beijing has intervened at the highest levels. Four national departments, including the State Administration for Market Regulation and the Ministry of Industry and Information Technology, have formed a joint task force to investigate the formamide claims. This top-down intervention signals that the government views the integrity of the infant supply chain—and the credibility of its regulatory oversight—as a matter of significant social stability.